6 completed, 1 active not recruiting, 1 recruiting. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 6, Active not recruiting 1, Recruiting 1 |
Follow Povorcitinib: new trials by email Literature Review of Povorcitinib trials Research Report on Povorcitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Povorcitinib - Hidradenitis Suppurativa (HS) | Phase 2 | Recruiting | Incyte Corporation | 40 | 2026-02-02 | 2026-10-09 |
| Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria Povorcitinib, Placebo - Urticaria, Chronic Spontaneous Urticaria | Phase 2 | Completed | Incyte Corporation | 136 | 2023-07-31 | 2026-03-12 |
| A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma povorcitinib, placebo, ICS-LABA - Moderate to Severe Asthma | Phase 2 | Active not recruiting | Incyte Corporation | 247 | 2023-07-11 | 2026-07-07 |
| A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis INCB054707, Placebo - Prurigo Nodularis | Phase 2 | Completed | Incyte Corporation | 146 | 2021-11-04 | 2025-07-11 |
| A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo INCB054707, Placebo - NonSegmental Vitiligo | Phase 2 | Completed | Incyte Corporation | 171 | 2021-05-06 | 2024-04-11 |
| To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa INCB054707, Placebo - Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Completed | Incyte Corporation | 209 | 2020-08-25 | 2025-08-12 |
| A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa INCB054707, Placebo - Hidradenitis Suppurativa | Phase 2 | Completed | Incyte Corporation | 35 | 2018-10-15 | 2025-08-21 |
| A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa INCB054707 - Hidradenitis Suppurativa | Phase 2 | Completed | Incyte Corporation | 10 | 2018-07-17 | 2022-09-26 |
Hidradenitis Suppurativa (4) · Angioedema (1) · Asthma (1) · Chronic Urticaria (1) · Hidradenitis (1) · Pruritus (1) · Skin Diseases (1) · Urticaria (1)
United States (7) · Canada (6) · Germany (5) · Poland (4) · Spain (3) · Argentina (1) · Denmark (1) · France (1) · Japan (1) · Puerto Rico (1)
PMID 34978076, PMID 40518122, PMID 42440041, PMID 42570211
2018 (1)